A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

NCT ID: NCT04658862

Last Updated: 2025-11-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

518 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-07

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of study is to compare bladder intact-event free survival (BI-EFS) in participants receiving TAR-200 in combination with intravenous (IV) cetrelimab versus concurrent chemoradiotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Bladder Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAR-200 + Cetrelimab

Participants will receive intravesical TAR-200 every 3 weeks (21 days indwelling) for first 18 weeks and thereafter from Week 24 every 12 weeks through study Year 3 in combination with intravenous (IV) Cetrelimab.

Group Type EXPERIMENTAL

Cetrelimab

Intervention Type BIOLOGICAL

Participants will receive intravenous Cetrelimab.

TAR-200

Intervention Type DRUG

Participants will receive intravesical TAR-200.

Chemotherapy (cisplatin or gemcitabine) + Radiation Therapy

Participants will receive chemotherapy based on investigator's choice from either cisplatin intravenously once weekly for 4 to 6 treatment weeks or gemcitabine intravenously twice weekly for 4 to 6 treatment weeks as Standard of Care (SOC) along with radiation therapy from either conventional radiotherapy (64 Gray \[Gy\], bladder only) for up to 6.5 treatment weeks or hypo-fractionated radiotherapy (55 Gy, bladder only) for up to 4 weeks.

Group Type ACTIVE_COMPARATOR

Cisplatin

Intervention Type DRUG

Participants will receive cisplatin intravenously.

Gemcitabine

Intervention Type DRUG

Participants will receive gemcitabine intravenously.

Conventional radiation therapy

Intervention Type RADIATION

Participants will receive conventional radiation therapy for bladder (64 gy).

Hypo-fractioned radiation therapy

Intervention Type RADIATION

Participants will receive hypo-fractioned radiation therapy for bladder (55 gy).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cetrelimab

Participants will receive intravenous Cetrelimab.

Intervention Type BIOLOGICAL

TAR-200

Participants will receive intravesical TAR-200.

Intervention Type DRUG

Cisplatin

Participants will receive cisplatin intravenously.

Intervention Type DRUG

Gemcitabine

Participants will receive gemcitabine intravenously.

Intervention Type DRUG

Conventional radiation therapy

Participants will receive conventional radiation therapy for bladder (64 gy).

Intervention Type RADIATION

Hypo-fractioned radiation therapy

Participants will receive hypo-fractioned radiation therapy for bladder (55 gy).

Intervention Type RADIATION

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

JNJ-63723283 JNJ-17000139

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ineligible for or have elected not to undergo radical cystectomy
* All adverse events associated with any prior surgery and/or intravesical therapy must have resolved to Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 Grade less than (\<) 2 prior to randomization
* Eastern Cooperative Oncology Group (ECOG) performance status Grade 0, 1, or 2
* Thyroid function tests are within the normal range per investigator assessment (or stable on hormone supplementation). Investigators may consult an endocrinologist for participant eligibility assessment in the case of equivocal or marginal test results
* Adequate bone marrow, liver, and renal function: Bone marrow function (without the support of cytokines or erythropoiesis-stimulating agent in preceding two weeks): Absolute neutrophil count (ANC) greater than or equal to (\>=) 1,500/cubic millimeters (mm\^3); Platelet count \>=80,000/mm\^3; Hemoglobin \>=9.0 grams per deciliter (g/dL); Liver function: (Total bilirubin less than or equal to (\<=) 1.5 \* upper limit of normal (ULN) or direct bilirubin \<= ULN for participants with total bilirubin levels greater than (\>)1.5\*ULN (except participants with Gilbert's Syndrome, who must have a total bilirubin \< 3.0 mg/dL), and Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) less than or equal to (\<=) 2.5\* institutional ULN); Renal function: Creatinine clearance \>=30 mL/min using the Cockcroft-Gault formula. 24-hour creatinine clearance test will also be accepted for estimating renal function in situations where Cockcroft-Gault formula is not a good predictor of estimating adequate renal function

Exclusion Criteria

* Must not have had urothelial carcinoma or histological variant at any site outside of the urinary bladder. Ta/T1/Carcinoma in situ (CIS) of the upper urinary tract (including renal pelvis and ureter) is allowable if treated with complete nephroureterectomy more than 24 months prior to initiating study
* Must not have diffuse CIS based on cystoscopy and biopsy. Diffuse, or multi-focal, CIS is defined as the presence of at least 4 distinct CIS lesions in the bladder at the time of the Screening re-TURBT
* Participants must not have evidence of cT4b, or N1-3, or M1 disease based on local radiology staging (chest, abdomen, and pelvis must be performed using Computed tomography \[CT\] or Magnetic resonance imaging \[MRI\]) within 42 days prior to randomization
* Presence of any bladder or urethral anatomic feature that, in the opinion of the investigator, may prevent the safe placement, indwelling use, or removal of TAR 200
* Evidence of bladder perforation during diagnostic cystoscopy. Participant is eligible if perforation has healed prior to randomization
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Janssen Research & Development, LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Janssen Research & Development, LLC Clinical Trials

Role: STUDY_DIRECTOR

Janssen Research & Development, LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda Univ Faculty Medic

Loma Linda, California, United States

Site Status

University of Southern California

Los Angeles, California, United States

Site Status

Providence Saint John s Health Center

Santa Monica, California, United States

Site Status

Stanford University Medical Center

Stanford, California, United States

Site Status

The Urology Center of Colorado

Denver, Colorado, United States

Site Status

Foothills Urology - Golden Off

Golden, Colorado, United States

Site Status

Boca Raton Regional Hospital

Boca Raton, Florida, United States

Site Status

Urological Research Network

Hialeah, Florida, United States

Site Status

Memorial Healthcare System

Pembroke Pines, Florida, United States

Site Status

Winship Cancer Institute of Emory University

Atlanta, Georgia, United States

Site Status

DuPage Medical Group

Lisle, Illinois, United States

Site Status

University Hospitals Seidman Cancer Center

Ann Arbor, Michigan, United States

Site Status

Michigan Institute of Urology

Troy, Michigan, United States

Site Status

Adult Pediatric Urology & Urogynecology, P.C

Omaha, Nebraska, United States

Site Status

Garden State Urology

Morristown, New Jersey, United States

Site Status

New Jersey Urology LLC

Voorhees Township, New Jersey, United States

Site Status

Cardiology Clinic at Montefiore Hutchinson Complex

The Bronx, New York, United States

Site Status

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Vidant Urology - Greenville

Greenville, North Carolina, United States

Site Status

Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center

Winston-Salem, North Carolina, United States

Site Status

Wexner Medical Center at the Ohio State University

Columbus, Ohio, United States

Site Status

Stephenson Cancer Center

Oklahoma City, Oklahoma, United States

Site Status

MidLantic Urology

Bala-Cynwyd, Pennsylvania, United States

Site Status

Carolina Urologic Research Center

Myrtle Beach, South Carolina, United States

Site Status

University of Tennessee Medical Center

Knoxville, Tennessee, United States

Site Status

Houston Metro Urology

Houston, Texas, United States

Site Status

University of Texas Medical Branch

League City, Texas, United States

Site Status

Virginia Oncology Associates

Norfolk, Virginia, United States

Site Status

Fundacion Intecnus

Bariloche, , Argentina

Site Status

Hospital Italiano de Buenos Aires

Buenos Aires, , Argentina

Site Status

Asociacion de Beneficencia Hospital Sirio Libanes

Buenos Aires, , Argentina

Site Status

Instituto Medico Especializado Alexander Fleming

Buenos Aires, , Argentina

Site Status

Centro de Urologia (CDU)

Ciudad Automoma Buenos Aires, , Argentina

Site Status

Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica

Córdoba, , Argentina

Site Status

Centro Urologico Profesor Bengio

Córdoba, , Argentina

Site Status

Sanatorio Allende Cerro

Córdoba, , Argentina

Site Status

Centro Oncologico Riojano Integral (Cori)

La Rioja, , Argentina

Site Status

Centro de Investigacion Pergamino SA

Pergamino, , Argentina

Site Status

CEDIC Centro de Investigaciones Clinicas

Viedma, , Argentina

Site Status

Flinders Medical Centre

Bedford Park, , Australia

Site Status

Krankenhaus der barmherzigen Schwestern

Linz, , Austria

Site Status

Universitaetsklinikum Salzburg Landeskrankenhaus

Salzburg, , Austria

Site Status

Medizinische Universitaet Wien

Vienna, , Austria

Site Status

Hopital Erasme

Anderlecht, , Belgium

Site Status

ZNA Middelheim

Antwerp, , Belgium

Site Status

AZ Sint-Lucas

Assebroek, , Belgium

Site Status

AZ Sint Jan Brugge Oostende AV

Bruges, , Belgium

Site Status

Az Groeninge

Kortrijk, , Belgium

Site Status

Algemeen Ziekenhuis Delta

Roeselare, , Belgium

Site Status

Fundacao Pio XII

Barretos, , Brazil

Site Status

Fundação Hospitalar São Francisco de Assis

Belo Horizonte, , Brazil

Site Status

Liga Paranaense de Combate ao Cancer

Curitiba, , Brazil

Site Status

Centro Regional Integrado de Oncologia CRIO

Fortaleza, , Brazil

Site Status

Clinica de Oncologia Reichow

Jardim Blumenau, , Brazil

Site Status

Fundacao Doutor Amaral Carvalho

Jaú, , Brazil

Site Status

Liga Norte Riograndense Contra O Cancer

Natal, , Brazil

Site Status

Associacao Hospitalar Moinhos de Vento

Porto Alegre, , Brazil

Site Status

Hospital das Clinicas de Porto Alegre

Porto Alegre, , Brazil

Site Status

Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS

Porto Alegre, , Brazil

Site Status

Hospital Regional do Cancer - Hospital de Esperança

Presidente Prudente, , Brazil

Site Status

Hospital Sao Rafael

Salvador, , Brazil

Site Status

CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia

Santo André, , Brazil

Site Status

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base

São José do Rio Preto, , Brazil

Site Status

Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo

São Paulo, , Brazil

Site Status

Hospital Alemao Oswaldo Cruz

São Paulo, , Brazil

Site Status

Fundacao Antonio Prudente A C Camargo Cancer Center

São Paulo, , Brazil

Site Status

Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE

São Paulo, , Brazil

Site Status

Sociedade Beneficente de Senhoras - Hospital Sirio Libanes

São Paulo, , Brazil

Site Status

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

São Paulo, , Brazil

Site Status

Centro Oncológico do Triângulo

Uberlândia, , Brazil

Site Status

McGill University Health Centre

Montreal, Quebec, Canada

Site Status

CHU de Quebec L Hotel Dieu de Quebec

Québec, Quebec, Canada

Site Status

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, Canada

Site Status

Chinese Academy of Medical Sciences(CAMS) & Peking Union Medical College(PUMC)

Beijing, , China

Site Status

Peking University First Hospital

Beijing, , China

Site Status

Peking University Third Hospital

Beijing, , China

Site Status

Beijing Hospital

Beijing, , China

Site Status

The First Hospital of Jilin University

Changchun, , China

Site Status

The Third Xiangya Hospital of Central Sourth University

Changsha, , China

Site Status

Hunan Cancer hospital

Changsha Shi, , China

Site Status

West China Hospital of Sichuan University

Chengdu, , China

Site Status

Chongqing University Cancer Hospital

Chongqing, , China

Site Status

Sun Yat Sen University Cancer Center

Guangzhou, , China

Site Status

Guangzhou First Municipal People's Hospital

Guangzhou, , China

Site Status

Zhejiang Provincial People's Hospital

Hangzhou, , China

Site Status

The First Hospital of Jiaxing

Jiaxing, , China

Site Status

Nanjing Drum Tower Hospital

Nanjing, , China

Site Status

Qingdao Municipal Hospital

Qingdao, , China

Site Status

Ruijin Hospital

Shanghai, , China

Site Status

Renji Hospital

Shanghai, , China

Site Status

Shengjing Hospital Of China Medical University

Shenyang, , China

Site Status

Tianjin Medical University Cancer Institute and Hospital

Tianjin, , China

Site Status

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, , China

Site Status

Wuhan Union Hospital

Wuhan, , China

Site Status

Wuhan Tongji Hospital Tongji Medical College

Wuhan, , China

Site Status

Yantai Yuhuangding Hospital

Yantai, , China

Site Status

Henan Cancer Hospital

Zhengzhou, , China

Site Status

Slezska nemocnice v Opave

Opava, , Czechia

Site Status

Fakultni nemocnice Plze

Plzen-Bory, , Czechia

Site Status

Fakultni nemocnice Kralovske Vinohrady

Prague, , Czechia

Site Status

Urocentrum Praha

Prague, , Czechia

Site Status

Vseobecna fakultni nemocnice v Praze

Prague, , Czechia

Site Status

Thomayerova nemocnice

Prague, , Czechia

Site Status

Fakultni nemocnice v Motole

Prague, , Czechia

Site Status

Nemocnice Na Bulovce

Prague, , Czechia

Site Status

Hopital Pellegrin CHU Bordeaux

Bordeaux, , France

Site Status

ICH Hopital A. Morvan

Brest, , France

Site Status

Hôpital Côte de Nacre

Caen, , France

Site Status

Pole Sante Leonard de Vinci

Chambray-lès-Tours, , France

Site Status

Clinique Sainte Marguerite

Hyères, , France

Site Status

CHRU Lille

Lille, , France

Site Status

Polyclinique de Limoges - Francois Chenieux

Limoges, , France

Site Status

Hôpital Edouard Herriot

Lyon, , France

Site Status

Institut Paoli-Calmettes

Marseille, , France

Site Status

Hôpital Européen

Marseille, , France

Site Status

Institut Regional du Cancer de Montpellier

Montpellier, , France

Site Status

CHU Nimes

Nîmes, , France

Site Status

Institut Mutualiste Montsouris

Paris, , France

Site Status

Hopital Europeen Georges-Pompidou

Paris, , France

Site Status

Hôpital Bichat - Claude Bernard

Paris, , France

Site Status

Hopital Tenon

Paris, , France

Site Status

Clinical La Croix Du Sud - Ramsay Santé

Quint-Fonsegrives, , France

Site Status

Centre hospitalier universitaire de St Etienne

Saint-Etienne, , France

Site Status

Centre Hospitalier Prive

Saint-Grégoire, , France

Site Status

Hopital Foch

Suresnes, , France

Site Status

Institut de Cancerologie de Lorraine

Vandœuvre-lès-Nancy, , France

Site Status

Gustave Roussy

Villejuif, , France

Site Status

Klinikum Augsburg

Augsburg, , Germany

Site Status

Staedtisches Klinikum Braunschweig

Braunschweig, , Germany

Site Status

Universitatsklinikum Carl Gustav Carus Dresden

Dresden, , Germany

Site Status

Urologicum Duisburg

Duisburg, , Germany

Site Status

Universitatsklinikum Dusseldorf

Düesseldorf, , Germany

Site Status

Klinik und Poliklinik für Urologie

Essen, , Germany

Site Status

Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus

Frankfurt am Main, , Germany

Site Status

Universitatsklinikum Frankfurt

Frankfurt am Main, , Germany

Site Status

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status

SLK-Kliniken Heilbronn - Klinikum am Gesundbrunnen

Heilbronn, , Germany

Site Status

Klinikum Herne - Urologie

Herne, , Germany

Site Status

Matthias Schulze - Germany

Markkleeberg, , Germany

Site Status

Universitatsklinikum Munster

Münster, , Germany

Site Status

Klinikum Nürnberg Nord - Hautklinik

Nuremberg, , Germany

Site Status

Krankenhaus der Barmherzigen Bruder Trier

Trier, , Germany

Site Status

Alexandra General Hospital of Athens

Athens, , Greece

Site Status

Metropolitan General A E

Cholargós, , Greece

Site Status

Athens Medical Center

Marousi, , Greece

Site Status

Metropolitan Hospital

Neo Faliro, , Greece

Site Status

Interbalkan Medical Center of Thessaloniki

Thessaloniki, , Greece

Site Status

Euromedica General Clinic

Thessaloniki, , Greece

Site Status

Clinic Agios Loukas

Thessaloniki, , Greece

Site Status

Papageorgiou General Hospital Of Thessaloniki

Thessaloniki, , Greece

Site Status

Anassa General Clinic

Volos, , Greece

Site Status

Eszak Pesti Centrumkorhaz Honvedkorhaz

Budapest, , Hungary

Site Status

Bajcsy-Zsilinszky Kórház és Rendelőintézet

Budapest, , Hungary

Site Status

Orszagos Onkologiai Intezet

Budapest, , Hungary

Site Status

Debreceni Egyetem Klinikai Kozpont

Debrecen, , Hungary

Site Status

Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz

Nyíregyháza, , Hungary

Site Status

Sujan Surgical Cancer Hospital & Amravati Cancer Foundation

Amravati, , India

Site Status

Bangalore Medical College and Research Institute

Bangalore, , India

Site Status

Acharya Tulsi Regional Cancer Treatment Research Institute

Bikaner, , India

Site Status

Shatabdi Super Speciality Hospital

Nashik, , India

Site Status

BLK Super Specialty Hospital

New Delhi, , India

Site Status

Aakash Healthcare Super Speciality Hospital

New Delhi, , India

Site Status

Rajiv Gandhi Cancer Institute & Research Centre

New Delhi, , India

Site Status

Indira Gandhi Institute of Medical Sciences

Patna, , India

Site Status

Jehangir Clinical Development Center Pvt Ltd

Pune, , India

Site Status

Ospedale San Donato

Arezzo, , Italy

Site Status

Fondazione del Piemonte per I Oncologia IRCC Candiolo

Candiolo, , Italy

Site Status

Ospedale Civile Ramazzini

Carpi, , Italy

Site Status

Ospedale Cannizzaro

Catania, , Italy

Site Status

Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia

Foggia, , Italy

Site Status

SPDC Villa Scassi

Genova, , Italy

Site Status

Ospedale San Martino

Genova, , Italy

Site Status

Ospedale Umberto I di Lugo

Lugo, , Italy

Site Status

Ospedale San Raffaele

Milan, , Italy

Site Status

Istituto Europeo di Oncologia

Milan, , Italy

Site Status

Azienda Ospedaliera Universitaria Federico II

Napoli, , Italy

Site Status

Istituto Oncologico Veneto - IRCCS

Padua, , Italy

Site Status

Azienda Sanitaria Locale Salerno - Po Andrea Tortora Di Pagani

Pagani, , Italy

Site Status

Azienda Ospedaliero Universitaria Pisana

Pisa, , Italy

Site Status

ASL Napoli 2 Nord-SM delle Grazie Hospital

Pozzuoli, , Italy

Site Status

Policlinico Universitario Agostino Gemelli

Roma, , Italy

Site Status

Azienda Ospedaliera Sant Andrea

Roma, , Italy

Site Status

Universita Campus Bio-Medico di Roma

Rome, , Italy

Site Status

Istituto Nazionale Tumori Regina Elena

Rome, , Italy

Site Status

Istituto Clinico Humanitas Rozzano, IRCCS

Rozzano, , Italy

Site Status

Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria alle Scotte

Siena, , Italy

Site Status

Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino

Torino, , Italy

Site Status

Ospedale di Circolo e Fondazione Macchi

Varese, , Italy

Site Status

Ospedale San Bortolo

Vicenza, , Italy

Site Status

Aso Co.,Ltd Iizuka Hospital

Iizuka, , Japan

Site Status

St Marianna University Hospital

Kanagawa, , Japan

Site Status

Nara Medical University Hospital

Kashihara, , Japan

Site Status

Saitama Medical University Hospital

Kawagoe-Shi, , Japan

Site Status

Kimitsu Chuo Hospital

Kisarazu-shi, , Japan

Site Status

Nagasaki University Hospital

Nagasaki, , Japan

Site Status

JOHAS Osaka Rosai Hospital

Osaka, , Japan

Site Status

Tokuyama Central Hospital

Shūnan, , Japan

Site Status

Toranomon Hospital

Tokyo, , Japan

Site Status

Nippon Medical School Hospital

Tokyo, , Japan

Site Status

Fujita Health University Hospital

Toyoake, , Japan

Site Status

Yamaguchi University Hospital

Ube, , Japan

Site Status

Yokohama City University Medical Center

Yokohama, , Japan

Site Status

Hospital Civil de Guadalajara Fray Antonio Alcalde

Guadalajara, , Mexico

Site Status

Consultorio Privado Dr Jose Arturo Rodriguez Rivera

Guadalajara, , Mexico

Site Status

Centro De Estudio Y Prevencion Del Cancer

Juchitán de Zaragoza, , Mexico

Site Status

Dr. Marco Antonio Badillo Santoyo

León, , Mexico

Site Status

Oncologia Integral Satelite

Mexico City, , Mexico

Site Status

i Can Oncology Center

Monterrey, , Mexico

Site Status

Centro de Investigacion Clinica Chapultepec

Morelia, , Mexico

Site Status

Oaxaca Site Management Organization S.C.

Oaxaca City, , Mexico

Site Status

Centro de Investigacion Clinica de Oaxaca

Oaxaca City, , Mexico

Site Status

Oncologico Potosino

San Luis Potosí City, , Mexico

Site Status

Investigación Biomedica para el desarrollo de Farmacos, S.A. de C.V.

Zapopan, , Mexico

Site Status

Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II

Siedlce, , Poland

Site Status

Centrum Medyczne Pratia Poznan

Skorzewo, , Poland

Site Status

Centralny Szpital Kliniczny MSWiA w Warszawie

Warsaw, , Poland

Site Status

Uniwersytecki Szpital Kliniczny

Wroclaw, , Poland

Site Status

Hospital Garcia de Orta

Almada, , Portugal

Site Status

Centro Hospitalar e Universitario de Coimbra

Coimbra, , Portugal

Site Status

Centro Hospitalar de Lisboa Central

Lisbon, , Portugal

Site Status

Fund. Champalimaud

Lisbon, , Portugal

Site Status

H. Santa Maria - Centro Hospitalar de Lisboa Norte

Lisbon, , Portugal

Site Status

Hospital de Sao Joao

Porto, , Portugal

Site Status

Altlay Regional Oncology Dispensary

Barnaul, , Russia

Site Status

Ivanovo Regional Oncology Dispensary

Ivanovo, , Russia

Site Status

Krasnoyarsk Regional Oncology Dispensary

Krasnoyarsk, , Russia

Site Status

Hertzen Oncology Research Institute

Moscow, , Russia

Site Status

A. Tsyb Medical Radiological Research Center

Obninsk, , Russia

Site Status

BHI of Omsk region Clinical Oncology Dispensary

Omsk, , Russia

Site Status

Ryazan State Medical University named after I.P.Pavlov

Ryazan, , Russia

Site Status

N.N. Petrov Research Institute Of Oncology

Saint Petersburg, , Russia

Site Status

Ogarev Mordovian State University

Saransk, , Russia

Site Status

State Medical Institution Oncological Center #2 of Healthcare Department at Krasnodar Regio

Sochi, , Russia

Site Status

Multifunctional clinical medical center 'Medical city'

Tyumen, , Russia

Site Status

Bashkir State Medical University

Ufa, , Russia

Site Status

Inje University Haeundae Paik Hospital

Busan, , South Korea

Site Status

Kyungpook National University Chilgok Hospital

Daegu, , South Korea

Site Status

Keimyung University Dongsan Hospital

Daegu, , South Korea

Site Status

Samsung Medical Center

Gangnam Gu, , South Korea

Site Status

National Cancer Center

Goyang-si, , South Korea

Site Status

Chonnam National University Hwasun Hospital

Hwasun-gun, , South Korea

Site Status

Gachon University Gil Medical Center

Namdong, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Severance Hospital

Seoul, , South Korea

Site Status

Gangnam Severance Hospital

Seoul, , South Korea

Site Status

The Catholic University of Korea Seoul St Mary s Hospital

Seoul, , South Korea

Site Status

Hanyang University Hospital

Seoul, , South Korea

Site Status

Pusan National University Yangsan Hospital

Yangsan, , South Korea

Site Status

Hosp Univ A Coruna

A Coruña, , Spain

Site Status

Hosp. Univ. Germans Trias I Pujol

Badalona, , Spain

Site Status

Fund. Puigvert

Barcelona, , Spain

Site Status

Hosp Univ Vall D Hebron

Barcelona, , Spain

Site Status

Hosp. Univ. Virgen de Las Nieves

Granada, , Spain

Site Status

Hosp. de Jerez de La Frontera

Jerez de la Frontera, , Spain

Site Status

Clinica Univ. de Navarra

Madrid, , Spain

Site Status

Hosp. Univ. 12 de Octubre

Madrid, , Spain

Site Status

Hosp. Univ. de La Paz

Madrid, , Spain

Site Status

Hosp Univ Hm Sanchinarro

Madrid, , Spain

Site Status

Corporacio Sanitari Parc Tauli

Sabadell, , Spain

Site Status

Hosp. Univ. Marques de Valdecilla

Santander, , Spain

Site Status

Instituto Valenciano de Oncologia

Valencia, , Spain

Site Status

Hosp. Clinico Univ. de Valencia

Valencia, , Spain

Site Status

Kaohsiung Medical University Chung Ho Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

National Taiwan University Hospital

Taipei, , Taiwan

Site Status

Tri-Service General Hospital

Taipei, , Taiwan

Site Status

Chang Gung Memorial Hospital Linkou Branch

Taoyuan District, , Taiwan

Site Status

Adana Baskent Yuregir Hospital

Adana, , Turkey (Türkiye)

Site Status

Yildirim Beyazit University Medical Faculty Ankara Atatürk Research and Training Hospital

Ankara, , Turkey (Türkiye)

Site Status

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Dokuz Eylul Universitesi Tip Fakultesi

Balçova, , Turkey (Türkiye)

Site Status

Bezmialem University Medical Faculty

Fatih, , Turkey (Türkiye)

Site Status

Medical Park Gaziantep Hastanesi

Gaziantep, , Turkey (Türkiye)

Site Status

Istanbul University Cerrahpasa Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Medeniyet University Goztepe Training and Research Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Izmir Medical Park Hospital

Izmir, , Turkey (Türkiye)

Site Status

Inonu University Medical Faculty

Malatya, , Turkey (Türkiye)

Site Status

Erciyes Univ MKD Hospital

Melikgazi, , Turkey (Türkiye)

Site Status

T.C. Saglik Bakanligi Ankara Numune Egitim ve Arastirma Hastanesi

Seyhan, , Turkey (Türkiye)

Site Status

Chernihivskyi oblasnyi onkolohichnyi dyspanser

Chernihiv, , Ukraine

Site Status

SE Dnipropetrovsk Medical Academy

Dnipro, , Ukraine

Site Status

Kharkiv Regional Clinical Hospital

Kharkiv, , Ukraine

Site Status

Khersonsky Regional Oncology Center

Kherson, , Ukraine

Site Status

Asklepion LLC

Kiev, , Ukraine

Site Status

Kyiv City Clinical Hospital #3

Kyiv, , Ukraine

Site Status

State Institution Academy Of Medical Sciences Of Ukraine

Kyiv, , Ukraine

Site Status

P.L. Shupyk National Medical Academy of Post-Graduate Education

Kyiv, , Ukraine

Site Status

Lviv Regional Clinical Hospital

Lviv, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel Netherlands South Africa United States Argentina Australia Austria Belgium Brazil Canada China Czechia France Germany Greece Hungary India Italy Japan Mexico Poland Portugal Russia South Korea Spain Taiwan Turkey (Türkiye) Ukraine

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17000139BLC3001

Identifier Type: OTHER

Identifier Source: secondary_id

2020-002620-36

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

2023-507188-21-00

Identifier Type: REGISTRY

Identifier Source: secondary_id

CR108917

Identifier Type: -

Identifier Source: org_study_id